Classifica tra le azioni
#10096
Beta Bionics, Inc. is a commercial-stage medical technology company dedicated... Beta Bionics, Inc. is a commercial-stage medical technology company dedicated to inventing, developing, and bringing to market solutions that improve the health and quality of life for individuals with diabetes who depend on insulin. The company's flagship product, the iLet Bionic Pancreas, is an automated insulin delivery system currently available for treating type 1 diabetes in adults and children aged six and older. In addition to its existing offering, Beta Bionics is actively developing several new innovations: a Patch Pump, designed as a tubeless insulin pump that adheres directly to the skin; the Bihormonal iLet, which integrates automated delivery of both insulin and glucagon; and an iLet system specifically adapted for individuals with insulin-dependent type 2 diabetes. To support its product pipeline, the company has forged strategic alliances, including a collaboration and licensing agreement with Xeris Pharmaceuticals, Inc. to develop and commercialize a glucagon formulation compatible with pumps. It also holds a development and commercialization agreement with Abbott Diabetes Care Inc. for an automated insulin delivery system. Established in 2015, Beta Bionics is headquartered in Irvine, California.
Prezzo delle azioni
$19.81
Ultima sincronizzazione: 2026-08-28
Capitalizzazione di mercato
$891.32M
Variazione (1 giorno)
1.39%
Variazione (1 anno)
5.16%
Scambia Beta Bionics, Inc. (BBNX)
Ricavi di Beta Bionics, Inc. (BBNX)
Ricavi nel Aug 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di Beta Bionics, Inc., i ricavi attuali dell'azienda (TTM) sono pari a 0. Nel 2026, l'azienda ha registrato ricavi di 0 uguale a i ricavi dell'anno 2026, che erano pari a 0. I ricavi rappresentano l'importo totale generato dalla vendita di beni o servizi. A differenza degli utili, le spese non vengono detratte.
Storico dei ricavi per Beta Bionics, Inc. da 2026 a 2026
Ricavi alla fine di ogni anno
| Anno |
Ricavi |
Cambia |
|
Non abbastanza dati per le date fornite. |
Ricavi di aziende simili o concorrenti
| Azienda |
Ricavi |
Differenza nei ricavi |
Il paese |
|
|
$46.59B |
-
|
US
|
|
|
$25.84B |
-
|
US
|
|
|
$35.48B |
-
|
IE
|
|
|
$21.00B |
-
|
US
|
|
|
- |
-
|
DE
|
